Using the lorenz curve to characterize risk predictiveness and etiologic heterogeneity

Epidemiology

Volumn 27, Issue 4, 2016, Pages 531-537

  Mauguen, Audrey ^a   Begg, Colin B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; INCOME; LORENZ CURVE; POPULATION DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROPHYLAXIS; PUBLIC HEALTH; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL CONCEPTS; AGE; BREAST FEEDING; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETICS; MENARCHE; MENOPAUSE; PARITY; RISK; STATISTICS;

TRANSCRIPTOME;

AGE FACTORS; BREAST FEEDING; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MENARCHE; MENOPAUSE; PARITY; PROBABILITY; RISK; RISK ASSESSMENT; STATISTICS AS TOPIC; TRANSCRIPTOME;

EID: 84964342326     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000499     Document Type: Article

References (31)

1. Steyerberg EW, Moons KG, van der Windt DA, et al.; PROGRESS Group. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10:e1001381.
2. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
3. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
4. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337-344.
5. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-72; discussion 207.
6. Brier GW. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78:1-3.
7. Gerds TA , Schumacher M. Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J. 2006;48:1029-1040.
8. Steyerberg E. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer 2010.
9. Huang Y, Pepe MS. Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods. Stat Med. 2010;29:1391-1410.
10. Pepe MS, Feng Z, Huang Y, et al. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol. 2008;167:362-368.
11. Janes H, Pepe M, Kooperberg C, Newcomb P. Identifying target populations for screening or not screening using logic regression. Stat Med. 2005;24:1321-1338.
12. Lorenz MO. Methods of measuring the concentration of wealth. J Am Stat Assoc. 1905;9:209-219.
13. Green C, Yu BN, Marrie RA. Exploring the implications of smallarea variation in the incidence of multiple sclerosis. Am J Epidemiol. 2013;178:1059-1066.
14. Hickson DA, Waller LA, Gebreab SY, et al. Geographic representation of the jackson heart study cohort to the African-American population in Jackson, Mississippi. Am J Epidemiol. 2011;173:110-117.
15. Perini E, Junqueira DR, Lana LG, Luz TC. Prescription, dispensation and marketing patterns of methylphenidate. Rev Saude Publica. 2014;48:873-880.
16. Duarte EC, Ramalho WM, Tauil PL, Fontes CJ, Pang L. The changing distribution of malaria in the Brazilian Amazon, 2003-2004 and 2008-2009. Rev Soc Bras Med Trop. 2014;47:763-769.
17. Hashemi H, Rezvan F, Fotouhi A, et al. Distribution of cataract surgical rate and its economic inequality in Iran. Optom Vis Sci. 2015;92:707-713.
18. Gail MH. Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med. 2011;30:1090-1104.
19. Petracci E, Decarli A, Schairer C, et al. Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst. 2011;103:1037-1048.
20. Llorca J, Delgado-Rodríguez M. Visualising exposure-disease association: the Lorenz curve and the Gini index. Med Sci Monit. 2002;8:MT193-MT197.
21. Gastwirth JL. A general definition of the Lorenz curve. Econometrica. 1971;39:1037-1039.
22. Gastwirth J, Modarres R, Efststhia B. The use of the Lorenz curve, Gini index and related measures of relative inequality and uniformity in securities law. Metron. 2005;63:451-469.
23. Milanovich B. A simple way to calculate the Gini coefficient, and some implications. Econ Lett. 1997;56:45-49.
24. Lubrano M. The econometrics of inequality and poverty. Lecture 4: Lorenz curves, the Gini coefficient and parametric distributions. Available at: http://www.vcharite.univ-mrs.fr/pp/lubrano/cours/Lecture-4.pdf. Accessed 5 June 2015.
25. Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst. 2002;94:1221-1226.
26. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886.
27. Begg CB, Satagopan JM, Berwick M. A new strategy for evaluating the impact of epidemiologic risk factors for cancer with application to melanoma. J Am Stat Assoc. 1998;93:415-426.
28. Gini C. Sulla misura della concentrazione e della variabilita dei caratteri. Atti d R Inst Veneto di scienze, lettere ed arti. 1914;73:1203-1248.
29. Lee WC. Probabilistic analysis of global performances of diagnostic tests: interpreting the Lorenz curve-based summary measures. Stat Med. 1999;18:455-471.
30. Sattin RW, Rubin GL, Wingo PA, et al. Oral-contraceptive use and the risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med. 1986;315:405-411.
31. Begg CB, Orlow I, Zabor EC, et al. Identifying etiologically distinct subtypes of cancer: a demonstration project involving breast cancer. Cancer Med. 2015;4:1432-1439.